RxSight, Inc. RXST Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $127.48M-5.2% | $134.48M-5.4% | $142.09M-3.4% | $147.06M-0.8% | $148.31M+6.0% | ||
| $29.3M-6.9% | $31.47M-11.5% | $35.55M-10.1% | $39.53M-5.2% | $41.72M+1.8% | ||
| $98.18M-4.7% | $103.01M-3.3% | $106.53M-0.9% | $107.53M+0.9% | $106.59M+7.7% | ||
| 77%+0.4pp | 76.6%+1.6pp | 75%+1.9pp | 73.1%+1.3pp | 71.9%+1.2pp | ||
| $37.65M-2.3% | $38.55M-0.8% | $38.85M+0.6% | $38.63M+5.2% | $36.7M+6.8% | ||
| $115.87M+2.9% | $112.65M-0.5% | $113.17M+1.6% | $111.43M+4.4% | $106.75M+5.2% | ||
| $153.53M+1.5% | $151.2M-0.5% | $152.02M+1.3% | $150.06M+4.6% | $143.45M+5.6% | ||
| -$55.35M-14.8% | -$48.19M-6.0% | -$45.48M-6.9% | -$42.53M-15.4% | -$36.86M0.0% | ||
| -43.4%-7.6pp | -35.8%-3.8pp | -32%-3.1pp | -28.9%-4.1pp | -24.9%+1.5pp | ||
| $17K-15.0% | $20K0.0% | $20K-4.8% | $21K-4.5% | $22K0.0% | ||
| -$46.59M-19.8% | -$38.88M-9.0% | -$35.66M-10.8% | -$32.18M-21.5% | -$26.49M+3.4% | ||
| $53K-18.5% | $65K-9.7% | $72K-4.0% | $75K+27.1% | $59K+18.0% | ||
| -$46.64M-19.8% | -$38.94M-9.0% | -$35.73M-10.8% | -$32.25M-21.5% | -$26.55M+3.3% | ||
| -36.6%-7.6pp | -29%-3.8pp | -25.1%-3.2pp | -21.9%-4.0pp | -17.9%+1.7pp | ||
| -$1.13-18.9% | -$0.95-8.0% | -$0.88-10.0% | -$0.80-19.4% | -$0.67+6.9% | ||
| -$52.02M-15.8% | -$44.93M-5.6% | -$42.55M-8.2% | -$39.32M-16.9% | -$33.63M-1.0% | ||
| -40.8%-7.4pp | -33.4%-3.5pp | -29.9%-3.2pp | -26.7%-4.1pp | -22.7%+1.1pp | ||
| -$55.35M-14.8% | -$48.19M-6.0% | -$45.48M-6.9% | -$42.53M-15.4% | -$36.86M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is RxSight, Inc.'s revenue?
- RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.
- Is RxSight, Inc. profitable?
- RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.
- What are RxSight, Inc.'s profit margins?
- Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.
- What is RxSight, Inc.'s earnings per share?
- RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
- Where does RxSight, Inc.'s income statement data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
